Lang F, Wöll E, Waldegger S, Friedrich F, Ritter M, Pinggera G, Kloiber K, Bichler I, Heitzenberger H, Maly K
Institute for Physiology, University of Innsbruck, Austria.
Agents Actions Suppl. 1992;38 ( Pt 2):73-80.
In NIH-3T3 fibroblasts expressing the ras oncogene (+ras) bradykinin (BK) elicits sustained oscillations (1/min) of cell membrane potential (PD) due to oscillations of intracellular calcium activity with subsequent activation of calcium sensitive K+ channels. In NIH-3T3 fibroblasts not expressing the oncogene (-ras), BK leads to a single transient hyperpolarization of the cell membrane, not followed by oscillations. The oscillations of cell membrane potential require the presence of extracellular calcium and are abolished by K+ channel blocker barium (1 mmol/l), as well as by calcium channel blockers cadmium (1 mmol/l), lanthanum (0.1 mmol/l) and nifedipine (10 mumol/l). However, the oscillations are not modified by 1 mumol/l nifedipine, or by other calcium channel blockers, such as verapamil (10 mumol/l) or diltiazem (10 mumol/l). Cell proliferation is inhibited by nifedipine (10 mumol/l) but not by verapamil or diltiazem, indicating that the oscillations of intracellular calcium are a prerequisite for the growth factor independent proliferation of ras oncogene expressing cells.
在表达ras癌基因(+ras)的NIH-3T3成纤维细胞中,缓激肽(BK)由于细胞内钙活性的振荡以及随后钙敏感性钾通道的激活,引发细胞膜电位(PD)的持续振荡(1次/分钟)。在不表达癌基因的NIH-3T3成纤维细胞(-ras)中,BK导致细胞膜单次短暂超极化,之后并无振荡。细胞膜电位的振荡需要细胞外钙的存在,并且会被钾通道阻滞剂钡(1毫摩尔/升)以及钙通道阻滞剂镉(1毫摩尔/升)、镧(0.1毫摩尔/升)和硝苯地平(10微摩尔/升)消除。然而,1微摩尔/升的硝苯地平或其他钙通道阻滞剂,如维拉帕米(10微摩尔/升)或地尔硫䓬(10微摩尔/升)并不会改变这种振荡。硝苯地平(10微摩尔/升)可抑制细胞增殖,但维拉帕米或地尔硫䓬则不会,这表明细胞内钙的振荡是表达ras癌基因的细胞在无生长因子情况下增殖的先决条件。